Daniel S. Lorrain

Chief Scientific Officer, Contineum Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$1.1M

Companies

Latest trade

Jul 9, 2026

Companies

Contineum Therapeutics, Inc.Chief Scientific Officer −$1.1M

Trades

CTNM Sold 25 shares at $16.00 · planned $0.0M Jul 9

CTNM Sold 1,015 shares at $16.00 · planned $0.0M Jul 8

CTNM Sold 8,353 shares at $15.84 · planned $0.1M Jul 1

CTNM Sold 28,826 shares at $16.04 · planned $0.5M Jun 30

CTNM Sold 4,170 shares at $13.16 · planned $0.1M Jun 1

CTNM Sold 4,170 shares at $13.12 · planned $0.1M May 1

CTNM Sold 4,170 shares at $13.43 · planned $0.1M Apr 6

CTNM Sold 4,170 shares at $15.01 · planned $0.1M Mar 2

CTNM Sold 3,824 shares at $16.01 · planned $0.1M Feb 25

CTNM Sold 4,300 shares at $16.03 · planned $0.1M Feb 24

CTNM Sold 100 shares at $16.00 · planned $0.0M Feb 19

CTNM Sold 400 shares at $16.00 · planned $0.0M Feb 11

CTNM Sold 4,170 shares at $14.94 · planned $0.1M Feb 3

CTNM Sold 4,170 shares at $10.44 · planned $0.0M Jan 5

CTNM Sold 4,170 shares at $12.23 · planned $0.1M Dec 23

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.